Prof. Dr. med. Richard P. Baum, PhD

nuclear mediicne, theranostics

User Score	Experience	Rating	Publications	Media Files	Online Consultations
97%	46 years	9.8/10	73	8	No

Overview

About the doctor

Prof. Dr. med. Richard P. Baum, PhD, is a highly distinguished figure in nuclear medicine with more than four decades of experience. Throughout his remarkable career, he has held prestigious positions, including Professor of Nuclear Medicine at the University of Frankfurt, Chairman of the THERANOSTICS Center for Molecular Radiotherapy, and President of the ICPO Academy. Dr. Baum's contributions to the field have been recognized with numerous awards, including the Mallinckrodt Prize and the SNMMI Saul Hertz Prize. With a focus on theranostics and precision oncology, Dr. Baum's research has led to groundbreaking advancements in the treatment of various cancers, particularly in prostate cancer patients. His extensive list of scientific publications showcases his expertise and commitment to improving patient outcomes through innovative approaches. Dr. Baum's leadership and expertise make him a valuable asset to the medical community, earning him a well-deserved reputation as a leading figure in nuclear medicine.

Gallery

Toronto - 2008 - PET/CT in NeuroEndocrine Tumours – Prof. Richard Baum, MD

“What’s NEW in PRRT,” by Dr. Richard Baum

Dr Richard Baum : Theranostics for Prostate

PRRNT of Neuroendocrine Tumors - Basic Principles and Clinical Results by Prof Richard Baum

Resume

CV (Curriculum Vitae)

Education

1974-1980 Doctor of Medicine (M.D.), Endocrinology, Johannes Gutenberg University Mainz
Specialist in Nuclear Medicine

Experience

1984-1987 Senior Physician, Frankfurt University Medical Center
1996-Present Professor of Nuclear Medicine, University of Frankfurt am Main, Germany
1997-2019 Chairman and Clinical Director, THERANOSTICS Center for Molecular Radiotherapy and Precision Oncology, ENETS Center of Excellence, Zentralklinik Bad Berka, Germany
2020 President of the ICPO Academy (International Centers for Precision Oncology), Chairman of the Scientific Advisory Board
2020 Head of THERANOSTICS Center, Curanosticum Wiesbaden, Frankfurt, Germany

Awards & Memberships

1989 Mallinckrodt Prize (German Society for Nuclear Medicine)
1990 The Mallinckrodt Award
1996 Sharabai Memorial Award (Society of Nuclear Medicine, India)
2003 “Docente Especial de Profesor Invitado” Inst. Sup. de Ciencias Med. Cuba
2010 FY Khoo Lecture and Award, Academy of Medicine and Radiological Society Singapore
2011 Agasthiar Prize of the Indian Society of Nuclear Medicine
2013 Re-election as President of the International Research Group for Immunoscintigraphy and Immunotherapy (IRIST)
2013 President of the World Association for Radionuclide and Molecular Therapy (WARMTH)
2014 The GLORINET Award
2015 Appointment as a member of the board of directors of the SNMMI, Center of Excellence for Therapy
2016 Appointment as a member of the SNMMI Publication Committee
2017 Appointment as a faculty member by ESMO (CUP and endocrine tumors)
2017 Henry Wagner, Jr., presentation at the SNNMI Annual Meeting in Denver
2018 Chair of the Oncology Section, Congress of the World Federation of Nuclear Medicine and Biology (WFNMB), Melbourne, Australia
2019 Co-Chair, Fifth World Theranostics Congress, Jeju, South Korea
2019 Visiting Professor, Academy of Sciences, Cancer Clinic of Peking University, China
2019 Associate Professor, Michigan State University
2019 Winner of the SNMMI Saul Hertz Prize